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Optimum killing of gram-negative bacteria in serum requires the participation of 
terminal components of the complement system, presumably through formation of a 
membrane attack complex (MAC) 1 containing complement components C5b6789 (1- 
3). Although it is clear that some gram-negative bacteria are highly resistant to serum 
killing in the presence of adequate antibody, the mechanism of this resistance is not 
known. 
In the preceding paper (4), we reported results of uptake and consumption of C3 
and terminal complement components by a smooth, serum-resistant strain of Salmonella 
minnesota  ($218)  and  a  rough,  serum-sensitive mutant  (Re595)  of the  above parent 
strain. We concluded that the mechanism of serum resistance in S. minnesota $218 does 
not involve a block in complement activation or in terminal complement component 
deposition on the bacterial surface but appears to be associated with a  failure of the 
components to remain surface bound. 
In  this  paper, we  report  studies  on  the  mechanism  of terminal  component  con- 
sumption and release from S. minnesota $218. Our results show that binding of C8 and 
C9 to stably bound C5b67  on the bacterial surface of $218  results in release of the 
MAC  without  bacterial  killing.  The  release  of C5b-8  and  C5b-9  appears  to  be 
associated  with  failure  of  the  complexes  to  bind  hydrophobically  in  the  outer 
membrane. 
Materials and Methods 
Buffers.  Veronal-buffered saline,  containing 0.1% gelatin,  0.15  mM CaCI2, and  1.0  mM 
MgCI2 (VBSG ÷+) was prepared; Hanks' balanced salt solution (HBSS) was purchased (Gibco 
Laboratories, Grand Island Biological Co., Grand Island, NY); and HBSS with 0.15 mM CaC12 
and 1.0 mM MgC12 (HBSS  +÷) was prepared. 
Bacteria.  S.  minnesota Re595  and  S.  minnesota $218  were  kindly  provided  by  Dr. Jacik 
Hawiger, Vanderbilt University, Nashville,  TE. Characteristics of these organisms and proce- 
dures for their growth are as previously reported (4). 
x Abbreviations used in this paper: CFU, colony-forming unit; DO(2, deoxycholate; HBSS, Hanks' balanced 
salt solution; HBSS  ++, HBSS with 0.15 mM CaCI2 and 1.0 mM MgCI2;  LPS, lipopolysaccharide; MAC, 
membrane  attack  complex;  PNHS,  pooled  normal  human  serum;  VBSG  ÷+,  veronal-buffered  saline 
containing 0.1% gelatin, 0.15 mM CaC12, and 1.0 mM MgC12. 
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Serum.  Serum was pooled from 10 normal volunteers. For some studies, C8-deficient serum 
was prepared. Pooled normal human serum (PNHS) was depleted of C8 immunochemically 
for these studies because of the recent finding that genetically deficient sera may not be deficient 
in all chains of the C8 molecule (5). PNHS was immunochemically depleted of hemolytic C8 
activity using a specific anti-C8 immunoabsorbant column. The IgG fraction of monospecific 
burro anti-human C8 serum was prepared by octanoic acid precipitation. The IgG pool was 
adjusted to OD2ao --  15.0 and was coupled to Sepharose 4BCL by cyanogen bromide. Serum 
depleted of C8 with this immunoahsorbant had <0.001% of the starting C8 titer but a normal 
CHso after C8 repletion. 
Quantitative Cultures.  Quantitative cultures were performed as described previously (4). 
Consumption of C8 and C9 Hemolytic Activity.  Measurements of hemolytic C8 and C9 titers 
were performed using 1.5 ×  10  v E'AC 1-7 cells in a total reaction volume of 0.5 ml after minor 
modifications of standard techniques (4). 
Purification and Iodination of Complement Components.  Purification of C5, C7, C8, and C9 was 
performed with minor modifications, as previously described by Hammer et al.  (6), from a 2- 
liter pool of fresh normal human plasma. The specific hemolytic activity per #g of the purified 
components and the corresponding titers in PNHS were: C5, 1,783 U//~g (275,000 U/ml); C7, 
2,096  U/~g  (223,  450  U/ml); C8,  2,530  U//~g  (150,000  U/ml); and C9,  331  U//~g (40,000 
U/ml). 
Radiolabeling of C5  and C7 with  125I was performed with  Bolton-Hunter reagent  (New 
England Nuclear, Boston, MA) by the Inman modification (4). Radioiodination  of C9 with Na 
1~5I or  with  Na  lalI  was  done  by  the  solid-phase glucose oxidase-lactoperoxidase method, 
(Enzymobeads; Bio-Rad Laboratories, Richmond, CA). Specific radioactivity of labeled com- 
5  5  125  6  131  ponents was: C5, 4.99 ×  10  cpm/pg; C7, 3.82 ×  10  cpm//~g;  I C9,  1.74 ×  10  cpm//~g;  I 
C9,  7.56  ×  105 cpm/pg.  Radiolabeling was  accomplished with minimum loss of functional 
activity. In the case oft9, the purified, unlabeled component competed on a  1:1 basis with the 
radiolabeled component for bacterial binding. 
Quantitation of Radiolabeled Component Binding to Bacteria.  Binding of radiolabeled components 
to bacteria was determined as previously described (4). Molecules of radiolabeled component 
bound per colony forming unit (CFU) were calculated from the specific cpm bound, the known 
original CFU, and the  specific  radioactivity of the  labeled component. Total molecules of 
component bound (labeled plus unlabeled) were then derived from the ratio of hemolytic units 
of unlabeled component to hemolytic units of labeled component in the reaction mixture. The 
ratio of C9 molecules to C7 molecules in fractions from sucrose density gradients was calculated 
from the ratio of total molecules of each component per fraction. All measurements were done 
in duplicate on at least two occasions. 
Elution Experiments.  Susceptibility of bound 125I C5 or  125I  C9  to removal from the bacterial 
outer membrane by salt, detergent, or protease was measured. Aliquots of 1-3 ml were removed 
after 15 min of incubation at 37°C from the reaction mixture of 10% PNHS or 10% C8D with 
$218 or Re595. The bacterial pellet was sedimented by centrifugation at 4,800 g for  10 min at 
4°C and washed twice in VBSG  ++.  Pellets were suspended to the original volume after the 
second wash in either (a) VBSG  ++ diluted 1:5 in 5% dextrose (DVBSG++),  (b)  HBSS  ++, (c) 
VBSG  +÷, (d)  1 M  NaCI with 0.15 mM CaCI~ +  1 mM MgCI2 (pH 7.4), (e) 0.01 M EDTA in 
PBS,  Or)  1.0% triton X-100, (g)  1.0% Na deoxycholate (pH 8.0), (h) 0.5% SDS, or (i)  1 mg/ml 
trypsin TPCK in VBSG  ++. These samples were incubated at 37°C for 30 min, and counts of 
125I C5 or 125I C9 remaining in the bacterial pellet at various times were measured as described 
under quantitation of radiolabeled component binding to bacteria. Counts in the supernatant 
were also measured to verify total input counts. 
Sucrose Density Gradient Ultracentrifugation.  A 10-40% sucrose density gradient in VBSG  ++ was 
prepared in 9/16" ×  3%" polyallomer tubes. Samples of 0.5 ml were layered onto the gradient 
and sedimented in an SW 50.1 rotor (Beckman Instruments, Inc., Fullerton, CA)  for  16 h at 
33,000  rpm at 4°C. Seven-drop fractions were collected and counted in a well-type gamma 
counter (Beckman Instruments, Inc.). 
Results 
Consumption  of C8 and C9 by Cell-bound C5b-7.  Our previous experiments had shown 
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when incubated in serum. It was essential to determine whether consumption of the 
latter components was a function of C5b-9 formation on the bacterial surface or was 
occurring predominantly via activation in the fluid phase. To address this question, 
$218 was incubated for 15 rain at 37°C in  10% C8D serum in VBSG  +÷. The reaction 
mixture  was  then  centrifuged  for  10  min  at  4,800 g  at  4°C,  the  supernatant  was 
removed onto ice, and the bacterial pellet was washed two times in VBSG  ++ at 4°C. 
Purified C8 was added to the supernatant from the original reaction mixture, C8 and 
C9 were added to the bacterial pellet, and both tubes were incubated for an additional 
30 min at 37°C. There was 56% depletion of C8 in the tube containing the bacteria 
but only 18% depletion of C8 in the supernatant tube (Table I). Total depletion of C9 
was observed in the tube containing the bacterial pellet, whereas only a  26%  fall in 
C9 titers occurred  in  the tube containing the supernatant.  Therefore,  the extensive 
consumption of C8 and C9 by $218 was apparently the result of interaction of these 
two components with C5b67 on the bacterial surface,  yet as previously shown, such 
interaction  resulted  in  inefficient  binding  of C9  to  the  organism.  The  following 
TABLE  I 
Consumption of C8 and C9 by the Supernatant and Pellet from S. minnesota $218 Incubated in CSD Serum 
C8  (]9 
Supernatant  Pellet  Supernatant  Pellet 
U/ml  added  5,800  5,800  3,800*  10,300 
U/ml  remaining  after  30-min  4,500 (18%)z~  2,400 (56%)  2,600 (26%)  8  (100%) 
incubation 
S. minnesota $218 was incubated  in  10% (]8D serum, and supernatant  and pellet samples were prepared 
as described in Results. Purified (]8 and (]9 were added as indicated, samples were incubated for 30 min 
at 37°(], and (]8 and (29 titers were measured. 
* C9 titer in  10% C8D serum after incubation  with $218 (no additional (]9 added). 
:~ Numbers  in  parentheses  represent  percent  depletion  relative  to  control  tubes  containing  (]8  or (]9  in 
VBSG  ÷* 
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Fro.  1.  Uptake  of  C5  and  (]7  by  S.  minnesota $218  in  10%  C8D  serum.  S.  minnesota $218 
(7.3  ×  10  s  cells/ml)  was  incubated  in  10% C8D  or  10%  PNHS  serum, containing  either  125I C5 
125  (A)  or  I  C7  (B).  After  15  min,  varying  quantities  of purified  C8 were added  to  aliquots  from 
the mixtures  containing  (]8D serum.  Binding  of x25I(]5 and  x~SIC7 was measured  at the indicated 
times.  10%  (]8D  (O---O);  10%  PNHS  (&  A).  For  (A),  10%  (]8D  +  11,500  U/ml  C8 
(C)---.--O);  for  (B),  10% (]8D  +  4,700 U/ml  C8/ml  (A--.--.A),  and  10% CSD  +  23,000  U/ml 
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experiments investigated the possibility that binding of C8 and/or C9 to cell-bound 
C:~b67 was responsible for release of the terminal complex from the organism. 
Uptake of 1251 C5 and 1251 C7 in  C8D Serum.  Measurement  of 125I C5  and  a25I C7 
uptake in C8D serum (Fig.  1 A, B) demonstrated that nearly twice as many molecules 
of C5  and  C7  were  bound  to  $218  in  10%  C8D  as  in  10%  PNHS.  Moreover, the 
kinetics of binding were totally different in C8D serum. Uptake of 125I C5 and 125I C7 
by $218 in  10% C8D serum increased to a  maximum that was not reached until  30 
min of incubation at 37°C; binding remained relatively stable during an additional 
30 min of incubation. In contrast, there was no difference in kinetics or extent of C5 
and  C7  uptake  on  Re  595  when  uptake  in  10%  PNHS and  10%  C8D  serum  was 
compared (data not shown). 
Therefore, binding of C5 and C7 on $218 in C8D serum was more extensive and 
more stable  than  was binding of these components in  PNHS. To prove that  labile 
binding of C5 and C7 on $218 in PNHS was a consequence of subsequent interaction 
with C8 and C9, purified C8 in various concentrations was added to C8D serum after 
15 min of incubation with $218.  Addition of 11,500  U/ml of C8 prevented further 
uptake of C5 (Fig.  1 A). Addition of as little as 4,700 U/ml C8 reduced deposition of 
C7, and 23,000 U/ml of CC, caused release of C7, paralleling the release observed in 
PNHS  (Fig.  1B).  These  results  suggested  that  binding of C8  to C5b67 on $218 is 
Release of CSb67 from  Washed $218 by Addition of C8, C9, or C8 plus C9 in the Absence of 
Serum.  The next experiments  investigated whether purified C8 alone was sufficient 
or the combination of purified C8 and C9 was required  for rapid release of C5b67 
from $218.  For these  experiments,  Re  595  and  $218 were  incubated  in  10%  C8D 
serum containing either 125I C5 or 125I C7. The mixture was incubated for 20 min at 
37°C, the bacteria were washed twice in VSBG  +÷ at 4°C and suspended in VBSG  ++ 
alone, VBSG  ++ with C8, VBSG  ++ with C9, or VBSG  ++ with C8 and C9.  13-18% of 
bound  125I C5  (Fig.  2A)  and  125I C7  (Fig.  2B)  was released  from $218 during the 
subsequent  incubation at 37°C in either VBSG  ++ or VBSG  ++ with C9.  Much more 
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FIG.  2.  Release of C5b67 from S. minnesota  $218 by addition of C8 or C8 plus C9. S. minnesota  $218 
(7.3 ×  108 cells/ml) was incubated for 30 min in  10% C8D serum, containing either 1~51 C5 (A) or 
125I C7 (B). Bacteria were washed twice in VBSG  +÷ and suspended in VBSG  ++ (0- -  -O), VBSG  ++ 
with 1.5 ×  104 U/ml C8 •  •, VBSG  ++ with [ X  104 U/ml C9 (A  A), or VBSG  ++ with t.5 
4  4  o  ×  10  U/ml C8 and  i  X  10  U/ml C9 ((D"-,-"~). Mixtures were incubated at 37  C, and samples 
125  125  125  were removed for measurement of  IC5 or  IC7 bound. The difference between release of  IC5 
or 1251C7 by C8 and release by C8 plus C9 was statistically significant (P <  0.05). K. A. JOINER, C.  H. HAMMER, E. J.  BROWN, AND M.  M.  FRANK  813 
extensive and rapid loss of bound 1~I C5 and l~I  C7 from $218 occurred during the 
first  15  min of incubation  in  tubes containing  either C8 or C8 and C9, in  parallel 
with the loss of fluid-phase C8 and C9 hemolytic activity (not shown). The percent 
release was consistently  10% greater with C8 and C9 than with C8 alone (P <  0.05). 
No difference in 125I C7 release at 30 min was noted when three concentrations of C9 
(2,500 U/ml, 5,000 U/ml,  10,000 U/ml) were compared in the presence of 15,000 U/ 
ml of C8  (data not shown).  In contrast  to S.  minnesota $218,  <6% release of 125I C5 
from Re595 was detected with addition of C8 or C8 and C9 (data not shown). 
These  experiments  indicated  that  binding  of C8  was  primarily  responsible  for 
release of C5b67 from $218. This was further explored by determining the concentra- 
tions of C8 required to effect release of 125I C7 bound to $218 by previous incubation 
in C8D serum. The percent of 125I C7 released increased markedly at low concentra- 
tions (1,000-2,500  U/ml) of added C8, but release approached ~80% assymtotically 
at higher concentrations  (5,000-14,000  U/ml) of C8. 
Sucrose Density  Gradient Ultracentrifugation.  The  size  distribution  of the  terminal 
components  bound  to  $218  and  that  of the  released  complex were  examined  by 
sucrose  density  gradient  uhracentrifugation.  The supernatant  from the  reaction  of 
10% PNHS containing 125I C7 and a31I C9 and either Re595 or $218 was centrifuged 
in a  linear  10-40% sucrose gradient.  A  high molecular weight peak containing both 
C7 and C9 was observed for $218  (Fig.  3A), sedimenting in the same region as the 
SC5b-9 peak from 10% PNHS incubated with 4 mg/ml of zymosan for 60 min. In the 
case of $218,  the ratio of C9:C7  in each tube of the left one-half of the C5b-9 peak, 
chosen to preclude contribution from free C7 or free C9, was a constant 3.3:1. 
The bacterial pellet from the incubation of $218 and 10% PNHS was washed twice 
in VBSG  ++ and then incubated in  1.0% Na deoxycholate (DOC), pH 8.0, for 30 min 
at 37°C. Sodium DOC does not disrupt the MAC (7) and was shown in other studies 
(see elution experiments) to extract 70% of bound C5 and C9 counts from the surface 
of $218. The bacterial pellet was removed, and the supernatant was centrifuged on a 
10-40% linear sucrose gradient containing  1.0% DOC. The C7 and C9 sedimented in 
a  large, broad peak in which the ratio of C9:C7 molecules never exceeded  1.2:1  (Fig. 
3 B). Small peaks for the native molecules were also observed and are consistent with 
DOC elution of nonspecifically bound C7 and C9. 
The complex released  by addition  of purified C8  and  131IC9 to $218,  previously 
incubated in C8D serum containing 125I C7, was also examined. The 125I C7 counts 
sedimented to the bottom of the gradient (Fig. 3 C), suggesting aggregation of the C7 
containing complexes. The ratio of C9:C7 in the complexes was 0.5:1, consistent with 
a  large fraction of the 125I C7 counts being in C5b-7 or C5b-8 complexes. 
Elution of C5b-7 and C5b-9 from $218 and Re 595 by Salt, EDTA, Detergent, and T~ypsin. 
The ability of salt, EDTA, detergent, or trypsin to elute C5b-7 and C5b-9 from $218 
and  Re595  was  examined.  Elution  of C5b-7  was  tested  after  incubation  of the 
organisms  in  10%  C8D  serum  containing  xzsI C5  (Fig.  4A).  Elution  of C5b-9 was 
evaluated after incubation of $218 and Re595 in 10% PNHS containing either 12zI C5 
(Fig. 4 B) or 1251 C9 (Fig. 4 C). Incubation in low ionic strength buffer led to release of 
neither C5b67 nor C5b-9 from Re595  and $218.  However, a  substantial  increase in 
elution  of C5b-7  and C5b-9  from $218  was observed with  incubation  in buffers of 
increasing ionic strength and after incubation in 0.01 M  EDTA. In contrast, <11% of 
C5b-7  and  C5b-9  eluted  from the  serum-sensitive Re595  in  1 M  NaC1  or 0.01  M 814  MECHANISM  OF  SERUM  RESISTANCE  IN  BACTERIA 
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EDTA buffer. The nonionic detergent triton X-100 was less effective in eluting C5b- 
7 and C5b-9 from either organism than were the ionic detergents, sodium DOC and 
sodium dodecyl sulfate. Trypsin cleaved 54-57% of 125I C5 (C5b-7 and C5b-9) counts 
and 25% of 1251 C9 counts from Re595, but cleaved >90% of lz5I C5 (C5b-7 and C5b- 
9) and 12~I C9 counts from $218. The addition of 2-mercaptoethanol after incubation 
with 0.1%  trypsin resulted in  no significant change in  release of C5  and  C9  from 
Re595 or $218.  The results from this series of experiments suggest that  binding of 
C5b67  and C5b-9 to $218 is mediated in large part  by ionic interactions, whereas 
attachment  of C5b67  and  C5b-9  to  Re595  is  mediated  through  predominantly 
hydrophobic bonds. Both C5 and C9 were more accessible to trypsin cleavage on the 
surface  of $218  than  on  the  surface  of Re595,  a  result  consistent  with  partial 
membrane shielding of C5b67 and C5b-9 on Re595. 
Discussion 
Incubation of serum-resistant S. minnesota  $218 in serum leads to activation of serum 
complement, deposition of terminal complement components on the organism, and 
release of the terminal components without bacterial killing (4). These studies explore 
the  mechanism  of terminal  component  consumption  and  release.  Initial  studies 
demonstrated that consumption of C8 and C9 occurred predominantly after interac- 
tion with C5b-7 bound to the bacterial surface. Subsequent experiments showed that 
C5b-7 bound extensively and stably in C8-deficient serum, but addition of C8 caused 
dose-dependent release of the terminal complex from the bacterial surface. 
There are several possibilities that may explain this finding. Part of the bacterial 
surface might be shed, carrying the terminal component complex into the fluid phase. 
However, we previously demonstrated <5% release of endogenously incorporated 14C 
and [14C]lipid from $218 when the organism was incubated in 10% PNHS. This fact, 
in conjunction with our demonstration that C3 remains firmly bound to $218 and the 
lack of electron microscopic evidence for outer membrane damage on $218, suggests 
that gross outer membrane damage or membrane loss does not explain the terminal 
component release. 
A  second possibility is that proteolysis of the surface-bound complement proteins 
ensued  with  the  addition  of C8  and  C9  to  C5b67  on  the  bacterial  surface.  This 
possibility seems unlikely. The proteolytic enzyme would have to spare C3 bound to 
the bacteria. Moreover, the complex released from $218 in 10% PNHS sedimented as 
a  typical  SC5b-9  complex containing  intact  C9,  as  analyzed  by  sodium  dodecyl 
sulfate-polyacrylamide gel electrophoresis (not shown).  Furthermore, release of ter- 
minal components from $218 was observed with bacteria that were killed by heating 
for 10 min at 80°C, conditions that would inactivate many bacterial proteases. 
A third and likely possibility to explain the release of C5b67 is that addition of C8 
Fie,.  3.  Sucrose density gradient uhracentrifgation of terminal component complexes released or 
eluted from S. minnesota $218. Samples were prepared as described below and were centrifuged for 
16 h at 33,000 rpm at 4°C. •  •,  1251 C7; 0-  -  -0, 131I C9. Panel A, S. minnesota $218 (7.3 ×  10  s 
cells/m1) was incubated for 20 min in 10% PNHS, containing ~zsI (37 and 131I C9. The supernatant 
was applied to a  10-40% sucrose gradient in VBSG  ++. Panel B, the bacterial pellet from the reaction 
described  in  panel  A  was  incubated  for  30  min at  37°C  in  1%  NaDOC.  The supernatant was 
applied to a  10-40% sucrose gradient in VBSG  ++ with  1% NaDOC.  Panel (3, $218 was incubated 
for  30  min  in  CSD  serum containing ~zsI (37  and  ~slI C9.  The bacterial  pellet  was washed in 
VBSG  ++, and  14,000 U/ml (38 and 4,000 U/ml (39 were added.  After incubation for 30 rain, the 
supernatant was applied to a  10-40% sucrose gradient in VBSG  ++. 816  MECHANISM  OF  SERUM  RESISTANCE  IN  BACTERIA 
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Fro.  4.  Elution of C5b67 and C5b-9 from S. minnesota Re595 and S. minnesota $218 by salt, EDTA, 
detergent; or trypsin. A, C5 (C8D serum); B, C5 (PNHS); C, C9 (PNHS). Bacteria were prepared 
as described under elution experiments in Materials and Methods. Washed organisms with bound 
C5b67  (A)  or C5b-9  (B  and C)  were then  incubated for 30  min at  37°C in  (a)  DVBSG  ++,  (b) 
HBSS  ÷÷, (c) VBSG  ++, (d) 1 M  NaCI, pH 7.4, with 0.15 mM CaCI2 and 1.0 mM MgCI2, (e) 0.01  M 
EDTA in PBS, (f)  1.0% triton X-100, pH 7.4, (g) 1.0% NaDOC, pH 8.0, (h) 0.5% SDS, and (i) and 
0") 0.1%  trypsin in VBSG  ++. At 30 min, the percent of 1~I C5 or 1~I C9 released was measured 
(tubes A-r). To tube J, 2-mercaptoethanol was added to a concentration of 1%, and released l~I C5 
and a~I C9 counts were determined after an additional 10-min incubation. Results shown are means 
of data from two to three experiments done in duplicate. Re595, D; $218, I. 
or C8 and C9 increases the hydrophobicity and decreases the degree of ionic binding 
of the  resultant  complex.  Release  of C5b-8  and  C5b-9  then  ensues  because,  as 
discussed below, these complexes are not attached by strong hydrophobic interactions 
to the outer membrane of the serum-resistant organism. Podack and MiJller-Eberhard 
(8)  demonstrated  that  C5b-6  and  C5b-7  bound,  respectively,  24  and  27  mol 
DOC/mol complex, but C5b-8 bound 63 mol, and C5b-9 bound 86 mol of DOC/mol 
of complex. Analogous results were obtained when phospholipid binding to complexes 
in DOC-phospholipid vesicles was studied (9). The molar phospholipid/protein ratios 
were C5b-7,  388:1;  C5b-8, 841:1;  C5b-9,  918:1;  and  C5b-9  dimer  (MAC),  1460:1. K. A. JOINER, C.  H. HAMMER, E. J.  BROWN, AND M.  M.  FRANK  817 
Our results, showing  13% release of C5b-7, 65% release of C5b-8, and 76% release of 
C5b-9 from $218, during incubation for 30 min at 37°C, are consistent with the idea 
that  increased  hydrophobicity leads  to  decreased ability of terminal  complexes to 
remain bound to the surface of $218. 
These results are consistent with the concept that  a  C5b-9 complex forms on the 
surface of $218, but the formed complex does not insert into hydrophobic regions in 
the outer membrane of the serum-resistant bacterium. Experiments on complement 
lysis of erythrocytes suggest that MAC insertion into hydrophobic membrane domains 
is necessary for lysis.  For example, the MAC  on erythrocyte membranes cannot be 
eluted by salt (10). Our results demonstrating minimum elution of C5b-7 and C5b-9 
from  serum-sensitive  Re595  by  incubation  in  buffers  of increasing  ionic  strength 
support  the  idea  that  ionic interactions are  not  prominent  in  binding of terminal 
components to Re595. In contrast, C5b67 and C5b-9 are eluted from $218 by salt, 
suggesting that these complexes are ionically bound to the bacterial surface. Further 
evidence  for  MAC  inserton  into  the  lipid  bilayer  of erythrocyte membranes  was 
provided by Hammer et al.  (10,  11). These workers showed that erythrocyte-bound 
C5b-7, C5b-8, or C5b-9 were partially resistant  to trypsin-mediated proteolysis and 
release and suggested that insertion into the lipid bilayer protected terminal compo- 
nents from trypsin attack. More recent findings (7,  12, 13) have raised questions as to 
the susceptibility of fluid-phase and  membrane-bound C5b-9  to proteolytic attack. 
Nevertheless, it is striking that the C5b-7 and C5b-9 complexes on the serum-resistant 
organism are more sensitive to trypsin-mediated release than are the complexes on 
the serum-sensitive bacteria. Either the molecular form of the terminal complex on 
$218 is different from that on Re595, or the complex on $218 is not inserted into the 
lipid  bilayer.  Our  finding  that  <5%  of [14C]lipid  is  released  from  $218  during 
incubation in  10% PNHS implies that C5b-9 is not interacting with and displacing 
outer membrane phospholipids. 
The  fluid-phase  complex  released  from  the  reaction  of $218  and  10%  PNHS 
sedimented as a typical SC5b-9 complex. In contrast, the complex released by addition 
of C8 and C9 to $218 previously incubated in C8D serum sedimented as an aggregate 
with a  C9:C7  ratio of 0.5:1.  This suggests that  the major form of C5b-7  bound to 
$218 lacks S protein, because S protein bound to C5b-7, C5b-8, or C5b-9 prevents 
aggregation of these complexes in aqueous solution (8). If this supposition is correct, 
the results imply that C8 releases C5b-7 from the resistant organism in the absence of 
S protein. 
The  lipopolysaccharides  (LPS)  of smooth,  gram-negative  bacteria  contain  long 
polysaccharide side chains  that  extend externally to the  lipid  portion of the outer 
membrane.  The polysaccharide portion of bacterial  LPS may activate the  human 
alternative complement pathway (14), and human serum contains natural antibodies 
to many of these O-specific polysaccharides. It is possible that activation of comple- 
ment by polysaccharide determinants in the LPS of $218 resulted in formation of a 
C5b-9 complex that was  physically separated  from the hydrophobic portion of the 
outer membrane. This may preclude insertion of C5b-9 into the hydrophobic domains. 
The relatively hydrophilic polysaccharide side chain might form a weak ionic binding 
site for the C5b-9 complex. Alternatively, the paucity of phospholipids in the outer 
membrane of smooth, gram-negative organisms  (15), the low fluidity of such mem- 
branes  (16), and the impermeability of these membranes to even very small hydro- 818  MECHANISM OF SERUM RESISTANCE IN BACTERIA 
phobic molecules (17) suggest that a MAC formed even in close proximity to the core 
outer membrane determinants might be incapable of insertion. 
These studies have explored the mechanism of resistance to serum killing of a gram- 
negative  bacterium,  S.  minnesota  $218.  Our  experiments  show  that  complement 
components are efficiently consumed by S.  minnesota  $218, and these components are 
deposited on the bacterial surface. However, C5b-9 is released and is not bactericidal 
because the complex does not insert into hydrophobic regions in the outer membrane. 
Gram-negative organisms cause the majority of bacteremias in hospitalized patients, 
most  of these  blood culture  isolates  are serum  resistant  (18),  and  bacteremia with 
serum-resistant  isolates  is  commonly associated with  shock  (19).  It  is  possible  that 
extensive generation of C3a and C5a by serum-resistant organisms, in the absence of 
bacterial  killing,  might  be responsible  for many of the  biologic effects observed in 
gram-negative bacteremia. 
Summary 
The mechanism for consumption of terminal complement components and release 
of bound  components  from the  surface of serum-resistant  Salmonella  minnesota  $218 
was studied. Consumption of C8 and C9 by $218 occurred through interaction with 
C5b67  on the bacterial surface because C8  and C9 were consumed when  added  to 
$218 organisms previously incubated in C8-deficient serum and washed to remove all 
but cell-bound C5b67.  Rapid release of t2~I C5 and  125I C7  from the membrane of 
$218 was dependent on binding of C8 because 125I C5 and 12~I C7 deposition in C8D 
serum was stable and was  twofold higher  in  C8D  than  in  PNHS,  and  addition  of 
purified C8 or C8 and C9 to $218 previously incubated in C8D serum caused rapid 
release of az~I C5 and 12~I C7 from the organism. Analysis by sucrose density gradient 
ultracentrifugation  of the  fluid  phase  from  the  reaction  of $218  and  10%  PNHS 
revealed a  peak consistent with SC5b-9, in which the C9:C7 ratio was 3.3:1, but the 
NaDOC extracted bound C5b-9 complex sedimented as a broad peak with C9:C7 of 
< 1.2:1.  Progressive elution of C5b67 and C5b-9 from $218 but not serum-sensitive S. 
minnesota  Re595 was observed with incubation in buffers of increasing ionic strength. 
Greater than 90% of the bound counts of 125I C5 or lzsI C9 were released from $218 
by incubation  in  0.1%  trypsin,  but  only  57%  of a25I C5  and  25%  of 125I C9  were 
released  by treatment  of Re595  with  trypsin.  These results  are consistent  with  the 
concept that C5b-9 forms on the surface of the serum-sensitive S. minnesota  Re595 and 
the serum-resistant S. minnesota  $218 in normal human serum, but the formed complex 
is released and is not bactericidal for $218 because it fails to insert into hydrophobic 
outer membrane domains. 
The authors would like to acknowledge the excellent  editorial assistance  of Karen Leighty in 
preparation of this manuscript. 
Received  for publication 15 September 1981 and in revised  form 24 November 1981. 
References 
1.  Goldman, J. N., S. Ruddy, K. F. Austen,  and D. S. Feingold.  1969. The serum bactericidal 
reaction. III. Antibody and complement requirements for killing a rough Escherichia coll.  J. 
Immunol. 102:1379. K. A. JOINER,  C.  H.  HAMMER,  E. J.  BROWN,  AND  M.  M.  FRANK  819 
2.  lnoue, K., K. Yonemasu, A. Takamizawa, and T. Amano.  1968. Studies on the immune 
bacteriolysis. XIV.  Requirement  of all  nine  components  of complement  for  immune 
bacteriolysis. Biken jr. 11:203. 
3.  Schreiber,  R.  D.,  D.  (2.  Morrison,  E.  R.  Podack,  and  H.  J.  Mfilter-Eberhard.  1979. 
Bactericidal activity of the alternative complement pathway generated from  11  isolated 
plasma proteins.J. Exp. Med.  149:870. 
4.  Joiner, K. A., (2. H. Hammer, E. J. Brown, R. J. (2ole, and M. M. Frank. 1982. Studies on 
the mechanism of bacterial resistance to complement-mediated killing. I. Terminal com- 
plement components are deposited and  released from Salmonella minnesota $218  without 
causing bacterial death..]. Exp. Med.  155:797. 
5.  Tschopp, J. G., A. F. Esser, T. J. Spira, and H. J. Miiller-Eberhard. 1981. Occurrence of an 
incomplete C8 molecule in homozygous (28 deficiency in man.J.  Exp. Med.  154:1599. 
6.  Hammer, (2. H., G. H. Wirtz, L. Renfer, H. D, Gresham, and B. F. Tack. 1981. Large scale 
isolation of functionally active components of the human complement system.J. Biol. Chem. 
256:3995. 
7.  Podack,  E.  R.,  and  H.  J.  M~iller-Eberhard.  1980. S(25b-9  complex  of complement: 
formation of the dimeric membrane attack complex by removal of S-protein. J.  lmmunol. 
124:1779. 
8.  Podack, E. R., and H. J. Mfiller-Eberhard. 1978. Binding of desoxycholate, phosphatidyl- 
choline vesicles, lipoprotein and of the S-protein to complexes of terminal complement 
components. J. Immunol.  12 h 1025. 
9.  Podack, E. R., G. Biesecker, and H.J. Mfiller-Eberhard. 1979. Membrane attack complex 
of complement:  generation of high-affinity phospholipid binding sites by fusion of five 
hydrophilic plasma proteins. Proc. Natl.  Acad. Sei. U. S. A. 76:897. 
10.  Hammer, (2. H., M. L. Shin, A. S. Abramovitz, and M. M. Mayer. 1977. On the mechanism 
of cell membrane damage by complement: evidence on  insertion of polypeptide chains 
from (28 and (29 into the lipid bilayer of erythrocytes. J. Immunol. 119:1. 
11.  Hammer, (2. H., A. Nicholson, and M. M. Mayer. 1975. On the mechanism of cytolysis by 
complement: evidence on insertion of (25b and C7 subunits of the C5b,6,7 complex into 
phospholipid bilayers of erythrocyte membranes. Proc. Natl.  Acad. Sci. U. S. A. 72:5076. 
12.  Bhakdi,  S.,  and J.  Tranum-Jensen.  1979. Evidence  for  a  two-domain  structure  of the 
terminal membrane (25b-9 complex of human complement. Proc. Natl.  Acad. Sci. U.  S. A. 
76:5872. 
13.  Yamamoto, K-I, and  S. Migita.  1981. Proteolysis of the monomeric and  dimeric (25b-9 
complexes of complement: alteration in the susceptibility to proteases of the (29 subunits 
associated with (25b-9 dimerization.  J. Immunol.  127:423. 
14.  Morrison, D. (2., and L. F. Kline. 1977. Activation of the classical and properdin pathways 
of complement by bacterial lipopolysaccharides (LPS). jr. Immunol. 118:362. 
15.  Smit, J.,  Y.  Kamio, and  H.  Nikaido.  1975. Outer  membrane  of Salmonella  typhimurium: 
chemical analysis and freeze-fracture studies with lipopolysaccharide mutants. J. Bacteriol. 
124:942. 
16.  Rottem, S, and L. Leive. 1977. Effect of variations in lipopolysaccharide  on the fluidity of 
the outer membrane of Escherichia coll. J. Biol.  Chem. 252:2077. 
17.  Nikaido, H.  1976. Outer membrane of Salmonella ~phimurium  transmembrane diffusion of 
some hydrophobic substances. Biochim. Biop@s. Acta. 433:118. 
18.  Roantree,  R.  J.,  and  L.  A.  Rantz.  1960.  A  study  of the  relationship of the  normal 
bactericidal activity of human serum to bacterial infection. J. Clin. Invest. 39:72. 
19.  Elgefors, B.,  and  S.  Oiling.  1978. The  significance of serum-sensitive bacilli in  gram- 
negative bacteremia. Scand..].  Infect. Dis.  10:203. 